Javascript must be enabled to continue!
Cardiorespiratory effects of chronic hyperoxia in neonatal rats
View through CrossRef
Rats reared in hyperoxia (60% O
2
) from birth exhibit abnormal respiratory control: normoxic ventilation is reduced at 4 and 7 d of age (i.e., P4 and P7), but not at P14,
and
the hypoxic ventilatory response (HVR) is blunted at P7 and P14, but not at P4 (Bavis et al.
J Appl Physiol
109: 796–803, 2010). To determine whether these respiratory deficits impair tissue O
2
delivery, arterial O
2
saturation (SpO
2
) and heart rate were measured by pulse oximetry at P4 and P14 for rats reared in 60% O
2
(Hyperoxia) or 21% O
2
(Control). At P4, Hyperoxia rats had lower SpO
2
(93.0±1.3 vs. 98.8±0.2%; mean±SEM) and lower heart rates (332±10 vs. 380±9 bpm) while in normoxia than Controls. SpO
2
was also lower in Hyperoxia rats at P14, but to a lesser extent (97.0±0.4 vs. 98.7±0.1%); heart rate was not different from Controls at P14. When exposed to hypoxia (12% O
2
), the drop in SpO
2
was greater in Hyperoxia rats than Controls; however, this difference was more pronounced at P14 (ΔSpO
2
= −42±2 vs. −24±2% in Controls), consistent with the blunted HVR of Hyperoxia rats at this age. Hyperoxia rats also had lower hematocrits at P4 and P14 and smaller hearts at P4. Therefore, Hyperoxia rats do not appear to compensate for low SpO
2
and heart rate by increasing blood O
2
capacity or stroke volume. Together, these data suggest that tissue O
2
delivery is compromised during both normoxia and acute hypoxia in neonatal rats reared in hyperoxia. Supported by NIH grant HL‐083972.
Title: Cardiorespiratory effects of chronic hyperoxia in neonatal rats
Description:
Rats reared in hyperoxia (60% O
2
) from birth exhibit abnormal respiratory control: normoxic ventilation is reduced at 4 and 7 d of age (i.
e.
, P4 and P7), but not at P14,
and
the hypoxic ventilatory response (HVR) is blunted at P7 and P14, but not at P4 (Bavis et al.
J Appl Physiol
109: 796–803, 2010).
To determine whether these respiratory deficits impair tissue O
2
delivery, arterial O
2
saturation (SpO
2
) and heart rate were measured by pulse oximetry at P4 and P14 for rats reared in 60% O
2
(Hyperoxia) or 21% O
2
(Control).
At P4, Hyperoxia rats had lower SpO
2
(93.
0±1.
3 vs.
98.
8±0.
2%; mean±SEM) and lower heart rates (332±10 vs.
380±9 bpm) while in normoxia than Controls.
SpO
2
was also lower in Hyperoxia rats at P14, but to a lesser extent (97.
0±0.
4 vs.
98.
7±0.
1%); heart rate was not different from Controls at P14.
When exposed to hypoxia (12% O
2
), the drop in SpO
2
was greater in Hyperoxia rats than Controls; however, this difference was more pronounced at P14 (ΔSpO
2
= −42±2 vs.
−24±2% in Controls), consistent with the blunted HVR of Hyperoxia rats at this age.
Hyperoxia rats also had lower hematocrits at P4 and P14 and smaller hearts at P4.
Therefore, Hyperoxia rats do not appear to compensate for low SpO
2
and heart rate by increasing blood O
2
capacity or stroke volume.
Together, these data suggest that tissue O
2
delivery is compromised during both normoxia and acute hypoxia in neonatal rats reared in hyperoxia.
Supported by NIH grant HL‐083972.
Related Results
Chronic hyperoxia augments the hypoxic ventilatory response in adult rats
Chronic hyperoxia augments the hypoxic ventilatory response in adult rats
Chronic hyperoxia during postnatal development causes long-lasting attenuation of the hypoxic ventilatory response (HVR) in rats, but similar exposures during adulthood do not atte...
Hyperoxia-Induced ΔR
1
Hyperoxia-Induced ΔR
1
Background and Purpose—
Acceleration of longitudinal relaxation under hyperoxic challenge (ie, hyperoxia-induced ΔR
1
) indic...
Abstract 3006: Hyperoxia may be a treatment option for NSCLC
Abstract 3006: Hyperoxia may be a treatment option for NSCLC
Abstract
Introduction: Many anti-tumor drugs have been developed, however, prognosis of NSCLC remains poor and new approaches for NSCLC treatment are expected. Lung ...
Upregulating carnitine palmitoyltransferase 1 attenuates hyperoxia-induced endothelial cell dysfunction and persistent lung injury
Upregulating carnitine palmitoyltransferase 1 attenuates hyperoxia-induced endothelial cell dysfunction and persistent lung injury
Abstract
Background
Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants that may cause long-term lung dysfunction. Accum...
Effects of Perinatal Hyperoxia on Breathing
Effects of Perinatal Hyperoxia on Breathing
Abstract
Air‐breathing animals do not experience hyperoxia (inspired O
2
> 21%) in nature, but pre...
Leptin Resistance Protects Mice from Hyperoxia-induced Acute Lung Injury
Leptin Resistance Protects Mice from Hyperoxia-induced Acute Lung Injury
Abstract
Rationale
Human data suggest that the incidence of acute lung injury is reduced in patients with type II diabete...
Gap Junction Protein Expression in Hyperoxia-Exposed Neonatal Rat Lung Tissue
Gap Junction Protein Expression in Hyperoxia-Exposed Neonatal Rat Lung Tissue
Abstract
Bronchopulmonary dysplasia (BPD) is a common devastating pulmonary complication in preterm infants. Gap junction is involved in many lung diseases. In this study, ...
Hyperoxia for accidental hypothermia and increased mortality: a post-hoc analysis of a multicenter prospective observational study
Hyperoxia for accidental hypothermia and increased mortality: a post-hoc analysis of a multicenter prospective observational study
Abstract
Background
Supraphysiologic oxygen administration causes unfavorable clinical outcomes in various diseases, including traumatic brain injur...

